3D Ready Organoid
| Cat No. | C-061 |
| Organism | Human |
| Tissue | Uterine |
| Disease | Cancer |
| Growth Properties | Embedded 3D Culture |
| Biosafety Level | 1 |
| Growth conditions | 37℃, 95% Air, 5% CO2 |
| Size/Quantity | 1 |
| Product format | Frozen |
| Shipping Info | Dry Ice |
| Storage conditions | Liquid Nitrogen |
View Product Image
Human Uterine Corpus Cancer Organoid is a patient-derived 3D tumor model developed from endometrial carcinoma tissue. It retains the original tumor’s morphological complexity, hormone receptor status, and genetic aberrations, including those commonly associated with type I and type II endometrial cancers. Cultured long-term under defined conditions, this organoid mimics key features of in vivo tumor physiology, making it a valuable tool for translational research and therapeutic innovation.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Human Uterine Corpus Cancer Organoids are 3D models derived from uterine cancer tissues, particularly endometrial carcinoma. These organoids replicate the key characteristics of the uterine corpus, including tumor heterogeneity, epithelial cell structure, and molecular features of the original tissue. They serve as an advanced platform for studying uterine cancer progression, drug response, and therapeutic resistance. Their use in preclinical drug testing, targeted therapy development, and personalized medicine helps researchers better understand the molecular pathways driving endometrial cancer and improve treatment outcomes.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
